Workflow
DQHK(000985)
icon
Search documents
大庆华科(000985) - 2025 Q1 - 季度财报
2025-04-25 12:50
Financial Performance - The company's operating revenue for Q1 2025 was ¥501,980,817.11, representing a 3.97% increase compared to ¥482,819,586.36 in the same period last year[3] - Net profit attributable to shareholders for Q1 2025 was ¥7,127,128.56, a significant increase of 93.95% from ¥3,674,785.42 in the previous year[3] - The net profit after deducting non-recurring gains and losses was ¥6,583,740.67, up 34.94% from ¥4,878,906.14 year-on-year[3] - Basic and diluted earnings per share for Q1 2025 were both ¥0.055, reflecting a 96.43% increase from ¥0.028 in the previous year[3] - Total operating revenue for the current period reached ¥501,980,817.11, an increase of 3.9% compared to ¥482,819,586.36 in the previous period[12] - Net profit for the current period was ¥7,127,128.56, representing a significant increase of 94.5% from ¥3,674,785.42 in the previous period[12] - The total comprehensive income attributable to the parent company reached CNY 7,127,128.56, compared to CNY 3,674,785.42 in the previous period, indicating a significant increase[13] - Basic and diluted earnings per share both improved to CNY 0.055 from CNY 0.028 year-over-year[13] Cash Flow - The net cash flow from operating activities increased by 30.18% to ¥41,161,748.29, compared to ¥31,620,128.89 in the same quarter last year[3] - Net cash flow from operating activities was CNY 41,161,748.29, up from CNY 31,620,128.89 in the previous period, reflecting a growth of approximately 30.5%[13] - Cash inflow from operating activities totaled CNY 620,737,007.22, slightly increasing from CNY 609,995,258.38[13] - Cash outflow from operating activities was CNY 579,575,258.93, compared to CNY 578,375,129.49 in the previous period, showing a marginal increase[14] - The net cash flow from investing activities was negative at CNY -24,372,680.64, worsening from CNY -6,450,969.28 in the previous period[14] - The net increase in cash and cash equivalents was CNY 16,789,067.65, down from CNY 25,169,159.61 in the previous period[14] - The ending balance of cash and cash equivalents stood at CNY 344,985,129.49, compared to CNY 336,208,944.19 at the end of the previous period[14] - The company did not report any investment income during the current period, contrasting with CNY 63,787.50 in the previous period[14] Assets and Liabilities - Total assets at the end of Q1 2025 were ¥694,661,424.67, a slight decrease of 0.36% from ¥697,155,250.75 at the end of the previous year[3] - Total liabilities decreased to ¥81,565,796.23 from ¥93,102,602.50, a reduction of 12.4%[11] - Current assets totaled ¥400,882,032.44, showing a slight increase from ¥394,602,398.65, an increase of 1.3%[10] - Non-current assets decreased to ¥293,779,392.23 from ¥302,552,852.10, a decline of 2.6%[10] - The company’s retained earnings increased to ¥127,345,773.97 from ¥120,218,645.41, a growth of 5.3%[11] Shareholder Information - The total number of common shareholders at the end of the reporting period was 8,613, with the largest shareholder, China Petroleum Daqing, holding 55.03% of the shares[6] - Shareholders' equity attributable to the parent company increased by 1.50% to ¥613,095,628.44 from ¥604,052,648.25 at the end of the previous year[3] Government Subsidies and Expenses - The company received government subsidies amounting to ¥655,732.44 during the reporting period, which are closely related to its normal business operations[4] - Total operating costs amounted to ¥492,511,772.44, up from ¥476,493,010.31, reflecting a rise of 3.4%[12] - The company reported a financial expense of -¥874,441.14, an improvement compared to -¥2,126,238.83 in the previous period[12] - Research and development expenses were ¥419,800.44, indicating investment in innovation[12] Other Information - The company does not have any significant changes in its non-recurring gains and losses items during the reporting period[5] - The company’s first quarter report for 2024 is unaudited, and the new accounting standards will be implemented starting in 2024[14]
大庆华科(000985) - 2024 Q4 - 年度财报
2025-04-25 12:50
Dividend and Shareholder Information - The company plans to distribute a cash dividend of 0.5 RMB per 10 shares to all shareholders, based on a total of 129,639,500 shares[3]. - The largest shareholder, China Petroleum Daqing Oilfield Company, holds 55.03% of the total shares, amounting to 71,339,700 shares[132]. - Daqing High-tech State-owned Assets Operation Company holds 8.47% of the shares, totaling 10,980,900 shares, with 5,490,000 shares pledged[132]. - The company proposed a cash dividend of ¥0.50 per 10 shares, amounting to a total cash dividend of ¥6,481,975.00, which is 100% of the profit distribution[96][97]. - The company reported a net profit of ¥14,795,400.00 for the period, with a distributable profit of ¥120,218,645.41[97]. Financial Performance - The company's operating revenue for 2024 was approximately ¥1.97 billion, a decrease of 1.54% compared to ¥2.00 billion in 2023[14]. - Net profit attributable to shareholders increased by 160.63% to approximately ¥14.80 million in 2024, up from ¥5.68 million in 2023[14]. - The net profit after deducting non-recurring gains and losses surged by 1,388.69% to approximately ¥15.48 million in 2024, compared to ¥1.04 million in 2023[14]. - Basic earnings per share rose by 160.50% to ¥0.1141 in 2024, compared to ¥0.0438 in 2023[14]. - Total assets at the end of 2024 were approximately ¥697.16 million, a decrease of 0.68% from ¥701.94 million at the end of 2023[15]. - Net assets attributable to shareholders increased by 3.07% to approximately ¥604.05 million at the end of 2024, compared to ¥586.06 million at the end of 2023[15]. Production and Capacity - The company reported a significant increase in the production capacity of C5 resources, reaching 4.5 million tons by the end of 2024, with a compound annual growth rate of 10.9%[22]. - The company's polypropylene production capacity has increased from 30,000 tons per year to 110,000 tons per year after three expansions[30]. - The company has a production capacity utilization rate of 97.02% for polypropylene and 100% for C9 series products[33]. - The sales volume in the chemical industry increased by 19.59% to 465,117.30 tons in 2024, up from 388,932.79 tons in 2023[47]. Research and Development - Research and development expenses decreased by 90.50% to ¥954,415.11, primarily due to a reduction in dedicated R&D personnel[52]. - The number of R&D personnel dropped by 89.66% from 58 in 2023 to 6 in 2024, significantly impacting the company's R&D capacity[53]. - The company has obtained a total of 16 national patents, including 11 invention patents, for its core technologies in C5 and C9 petroleum resins[38]. Environmental and Safety Compliance - The company reported a 100% compliance rate in safety and environmental monitoring during the reporting period[41]. - The company achieved a 100% compliance rate for the disposal of waste gas, waste water, and solid waste during the reporting period[107]. - The company has no records of environmental complaints, violations, or penalties during the reporting period[113]. - The company invested a total of 6.7172 million yuan in environmental governance and protection during the reporting period[111]. Governance and Management - The company maintains a fully independent operational structure, ensuring separation from its controlling shareholder in all aspects[68]. - The company is committed to maintaining stability in its leadership, with all current directors and supervisors serving until at least September 2026[73]. - The company has established a compensation and assessment committee responsible for evaluating senior management and determining their remuneration[83]. - The total number of employees at the end of the reporting period is 450, with 309 in production, 10 in sales, 86 in technology, 10 in finance, and 35 in administration[92]. Related Party Transactions - The total amount of related party transactions for the company reached 241,780.57 million CNY, with 99.83% of transactions priced at market rates[122]. - The company engaged in procurement transactions with Daqing Petrochemical, amounting to 199,215.31 million CNY, representing 93.27% of similar transaction amounts[121]. - The company accepted labor services from Daqing Petrochemical Construction, totaling 3,048.88 million CNY, which exceeded the approved transaction limit by 30.99%[121]. Audit and Financial Reporting - The audit report issued by Tianjian Accounting Firm confirmed that the financial statements fairly reflect the company's financial position as of December 31, 2024[144]. - The audit identified revenue recognition as a key audit matter due to the inherent risks associated with management's potential inappropriate revenue recognition practices[146]. - Management is responsible for preparing financial statements in accordance with accounting standards and ensuring the absence of material misstatements due to fraud or error[151]. Future Outlook and Strategy - The company anticipates stable growth in the chemical products market, despite challenges from geopolitical tensions and trade policy uncertainties[21]. - The focus will be on technological innovation and the development of high-value products in the new energy and new materials sectors[64]. - The company plans to enhance its governance structure and management efficiency to achieve high-quality sustainable development[63].
大庆华科(000985) - 大庆华科股份有限公司市值管理制度
2025-04-25 12:50
大庆华科股份有限公司 市值管理制度 第一章 总则 第一条 为切实推动大庆华科股份有限公司(以下简称"公司") 提升投资价值,增强投资者回报,加强公司市值管理,维护公司、投 资者及其他利益相关方的合法权益,根据《中华人民共和国公司法》 《中华人民共和国证券法》《上市公司信息披露管理办法》《上市公司 监管指引第 10 号——市值管理》等法律法规、规范性文件及《大庆 华科股份有限公司章程》(以下简称《公司章程》)的规定,结合公司 实际情况,制定本制度。 第二条 本制度所称市值管理,是指以提高公司质量为基础,为 提升公司投资价值和股东回报能力而实施的战略管理行为。 第三条 公司应当牢固树立回报股东意识,采取措施保护投资者 尤其是中小投资者利益,诚实守信、规范运作、专注主业、稳健经营, 以新质生产力的培育和运用,推动经营水平和发展质量提升,并在此 基础上做好投资者关系管理,增强信息披露质量和透明度,必要时积 极采取措施提振投资者信心,推动公司投资价值合理反映公司质量。 第四条 公司应当积极做好与股东的沟通,引导股东长期投资。 第二章 市值管理的目的与基本原则 第五条 市值管理的主要目的是通过制定正确发展战略、完善公 司 ...
大庆华科(000985) - 大庆华科股份有限公司2024年独立董事年度述职报告(王涌)
2025-04-25 12:50
王涌:1966年8月出生,中国国籍,无境外永久居留权, 研究生学历,副教授。历任哈尔滨科技大学教师,哈尔滨 理工大学教师、副主任,哈尔滨理工大学经济与管理学院 会计系主任。现任哈尔滨理工大学经济与管理学院教师。 2020 年 5 月起任公司独立董事。 2、独立性情况说明 作为公司的独立董事,未在公司担任除独立董事以外 的任何职务,本人及直系亲属、主要社会关系均未在公司 任职,亦不存在为公司及控股股东或者其附属企业提供财 务、法律、咨询等服务的情形,不存在妨碍本人进行独立 客观判断的情形,亦不存在违反《上市公司独立董事管理办 法》第六条规定的独立董事任职独立性要求的情形。 大庆华科股份有限公司 2024 年度独立董事述职报告 (王涌) 本人王涌,作为大庆华科股份有限公司(以下简称"公 司")独立董事,严格按照《公司法》《证券法》《上市公司治 理准则》《上市公司独立董事管理办法》《深圳证券交易所上 市公司自律监管指引第 1 号—主板上市公司规范运作》等有 关法律法规和《公司章程》《独立董事工作制度》等相关规定, 本着恪尽职守、勤勉尽责的工作态度,积极出席公司股东 大会、董事会及各专门委员会,认真审议董事会各项议案 ...
大庆华科(000985) - 董事会对独立董事独立性评估的专项意见
2025-04-25 12:50
根据中国证券监督管理委员会《上市公司独立董事管理办法》《深圳 证券交易所股票上市规则》《深圳证券交易所上市公司自律监管指引第1 号——主板上市公司规范运作》等要求,大庆华科股份有限公司(以下简 称"公司")董事会,就公司在任独立董事王涌先生、李国峰先生、赵云 宝先生、潘明先生的独立性情况进行评估并出具如下专项意见: 经核查独立董事王涌先生、李国峰先生、赵云宝先生、潘明先生的任 职经历以及签署的相关自查文件,上述人员及直系亲属、主要社会关系均 未在公司担任除独立董事以外的任何职务,也未在公司主要股东公司担任 任何职务;不存在为公司及控股股东或者其附属企业提供财务、法律、咨 询等服务的情形;与公司以及主要股东之间不存在利害关系或其他可能妨 碍其进行独立客观判断的关系,不存在影响独立董事独立性的情况。符合 《上市公司独立董事管理办法》《深圳证券交易所上市公司自律监管指引 第1号——主板上市公司规范运作》中对独立董事独立性的相关要求。 大庆华科股份有限公司 董事会对独立董事独立性评估的专项意见 大庆华科股份有限公司董事会 2025年4月24日 ...
大庆华科(000985) - 大庆华科股份有限公司2024年独立董事年度述职报告(赵云宝)
2025-04-25 12:50
大庆华科股份有限公司 2024 年度独立董事述职报告 (赵云宝) 作为大庆华科股份有限公司(以下简称"公司")的独立 董事,本人严格按照《中华人民共和国公司法》《深圳证券交 易所股票上市规则》《上市公司自律监管指引第 1 号——主板 上市公司规范运作》等法律法规规范以及《公司章程》《公司 独立董事工作制度》等有关规定的要求,切实履行独立董事 忠实诚信和勤勉尽责的义务,积极出席相关会议,认真审 议董事会各项议案,全面关注公司的经营状况、内部控制 的建设情况及董事会决议执行情况,积极参与公司治理, 为公司经营和发展提出合理化的意见和建议,努力维护公 司和全体股东,特别是中小股东的合法权益。现就本人 2024 年履职情况汇报如下: 一、基本情况 1、个人简历及兼职情况 赵云宝,男,1971 年 6 月出生,中国国籍,无境外永久 居留权,大专学历,注册会计师。历任深圳君益投资有限 公司投资顾问,大庆和平资产评估所员工,黑龙江安联会 计师事务所大庆分公司负责人。现任黑龙江鸿联会计师事 务所有限公司总经理。2023 年 9 月起任公司独立董事。 2、独立性情况说明 作为公司的独立董事,未在公司担任除独立董事以外 的任何职 ...
大庆华科(000985) - 大庆华科股份有限公司2024年独立董事年度述职报告(潘明)
2025-04-25 12:50
大庆华科股份有限公司 2024 年度独立董事述职报告 (潘明) 二、2024 年履职情况 1、出席股东大会及董事会情况 2024年度,公司共召开4次董事会,本人应出席4次, 实际出席 4 次。其中,现场出席 1 次,委托其他独立董事出 席会议 1 次,以通讯方式参加 2 次,无缺席情况。 1 作为大庆华科股份有限公司(下称"公司")的独立董事, 根据《中华人民共和国公司法》《上市公司独立董事管理办法》 等法律法规和《公司章程》《独立董事制度》的规定和要求, 本人在 2024 年度工作中,履行了勤勉尽责的义务,积极出 席相关会议,认真审议董事会的相关议案并发表了独立意 见,切实维护了公司和股东尤其是中小股东的利益。现就 2024 年度履职情况作如下报告: 一、基本情况 截至 2024 年 12 月 31 日,本人基本情况如下: 潘明,男,1994 年 10 月出生,中国国籍,无境外永久 居留权,研究生学历,律师。历任黑龙江省上图教育科技 有限公司、黑龙江省法中教育科技有限公司法务助理、北 京大成(哈尔滨)律师事务所律师、北京市京师(哈尔滨) 律师事务所律师等职务。现任职黑龙江法联律师事务所律 师,2023 年 ...
大庆华科(000985) - 大庆华科股份有限公司2024年独立董事年度述职报告(李国峰)
2025-04-25 12:50
大庆华科股份有限公司 2024 年度独立董事述职报告 (李国峰) 本人李国峰,作为大庆华科股份有限公司(以下简称 "公司")独立董事,严格按照《公司法》《证券法》《上市公司 治理准则》《上市公司独立董事管理办法》《深圳证券交易所 上市公司自律监管指引第 1 号—主板上市公司规范运作》等 有关法律、法规和《公司章程》《独立董事工作制度》等相关 规定,本着恪尽职守、勤勉尽责的工作态度,积极出席公 司股东大会、董事会及各专门委员会,认真审议董事会各 项议案,积极履行独立董事职责,并按规定对公司董事会 审议的相关事项发表了独立客观的意见,充分发挥独立董 事的作用,维护公司股东尤其是中小股东的合法利益。 2024 年度,公司召开了股东大会会议 2 次,董事会会 议 4 次,其中现场方式召开 2 次,通讯方式召开 2 次。本人 出席会议情况如下: 一、基本情况 1、个人简历及兼职情况 李国峰:1968年5月出生,中国国籍,无境外永久居留 权,博士研究生学历,副教授。曾任东方企业集团绥芬河 办事处主任、哈尔滨工业大学科技开发总公司部门经理。 现任哈尔滨工业大学经济与管理学院教师。2023 年 9 月起 任公司独立董事。 2 ...
大庆华科收盘上涨3.05%,滚动市盈率42.04倍,总市值21.00亿元
Sou Hu Cai Jing· 2025-04-14 08:40
Group 1 - The core viewpoint of the article highlights Daqing Huake's stock performance, with a closing price of 16.2 yuan, an increase of 3.05%, and a rolling PE ratio of 42.04 times, with a total market value of 2.1 billion yuan [1] - The company operates in the petrochemical industry, producing and selling various products including C9 and C5 series petroleum resins, refined acetonitrile, polypropylene powder, and modified polyolefin plastics [1] - Daqing Huake has achieved significant technological advancements, holding 13 national patents, including 8 invention patents, all of which have been industrialized, indicating a leading position in domestic technology [1] Group 2 - The latest financial results for the third quarter of 2024 show that the company achieved an operating income of 1.505 billion yuan, a year-on-year increase of 4.41%, and a net profit of 31.1297 million yuan, a year-on-year increase of 336.63%, with a gross profit margin of 7.73% [1] - In terms of market performance, Daqing Huake ranks 112th in the chemical products industry, which has an average PE ratio of 50.85 times and a median of 36.13 times [2] - The net inflow of main funds for Daqing Huake on April 14 was 139,500 yuan, although there was an overall outflow of 5.9542 million yuan over the past five days [1]
大庆华科收盘上涨3.27%,滚动市盈率40.97倍,总市值20.47亿元
Sou Hu Cai Jing· 2025-04-10 08:41
Core Viewpoint - Daqing Huake's stock price increased by 3.27% to 15.79 yuan, with a rolling PE ratio of 40.97 times, and a total market value of 2.047 billion yuan [1] Company Overview - Daqing Huake specializes in the production and sales of petrochemical products, including C9 and C5 series petroleum resins, refined acetonitrile, polypropylene powder, and modified polyolefin plastics [1] - The company holds 13 national patents, including 8 invention patents, all of which have been industrialized, with its product technology at a leading domestic level [1] Financial Performance - For the third quarter of 2024, Daqing Huake reported operating revenue of 1.505 billion yuan, a year-on-year increase of 4.41%, and a net profit of 31.1297 million yuan, a year-on-year increase of 336.63%, with a gross profit margin of 7.73% [1] Shareholder Information - As of September 30, 2024, Daqing Huake had 9,251 shareholders, an increase of 170 from the previous count, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Industry Comparison - The average PE ratio for the chemical products industry is 47.84 times, with a median of 35.68 times, placing Daqing Huake at the 112th position in the industry [2]